Ap. Cosgrove et al., BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER-LIMB IN CEREBRAL-PALSY, Developmental Medicine and Child Neurology, 36(5), 1994, pp. 386-396
The role of intramuscular botulinum toxin A in the treatment of 26 chi
ldren with cerebral palsy was evaluated. The indication for injection
was the presence of a dynamic contracture of lower-limb muscles interf
ering with positioning or walking. Spastic target muscles were identif
ied by clinical examination and, in ambulant children, by gait analysi
s. Between 50 and 320 units of botulinum toxin were injected into each
muscle group to a total dose of 100 to 400 units per child. The effec
ts of injection were monitored by repeated clinical examination and ga
it analysis. There were no clinically detectable systemic side-effects
, and all but one patient had a reduction in tone, which occurred with
in three days and persisted for two to four months. There were signifi
cant improvements in ambulatory status and in sagittal-plane kinematic
s. in some cases these gains persisted after the tone-reducing effects
of the toxin had worn off.